Who are Exthymic's investors?

Exthymic's investors include KdT Ventures.

How much funding has Exthymic raised?

Exthymic has disclosed $10.2M raised across 1 round.

Where is Exthymic headquartered?

Exthymic is headquartered in San Diego, US.

Exthymic

San Diego, US · Founded 2023 · Delaware corporation · 16 employees on LinkedIn · 1 known investors

Find your way into Exthymic

Paths you didn't know you had: your email and LinkedIn already hold routes to the Exthymic team. We find them for you
2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them. The founders describe backgrounds building manufacturing platforms and scaling production within the cell therapy industry.

Biotech Healthtech

Founders & leadership

Rich StonerChief Executive Officer

Investors · 1

KdT VenturesreportedAustin · $500K – $3M

How we know: the VCSheet dataset · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$10.2M disclosed across 1 round · 2024

▶$10.2MraisedMay 2024 · 8 investors · Other Health Care

Rule 506(b)

Officers, directors & promoters on the filing

Rich StonerExecutive Officer, Director

Offering amount: $10.2M
Amount sold: $10.2M
First sale: Apr 2024
Incorporated: Corporation, Delaware, 2023
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 6

AptimAPTIM provides integrated resilience and infrastructure solutions including emergency management, infrastructure management, specialized engineering, and oil and gas facility services to government, commercial, industrial, and energy customers.

PlexiumPlexium is a targeted protein degradation company developing small molecule therapeutics for treating diseases with high unmet medical needs using their proprietary DELTA Discovery platform.

SensoriumSensorium Technological Laboratories is a Vanderbilt University spin-off that designs nanostructured metamaterials with tailored photonic properties, combining hyperspectral imaging with AI for sensing, detection, and metrology. Its products target the semiconductor industry, including defect detection for advanced packaging, along with gas detection and climate-tech applications.

LeadIQLeadIQ offers a company search tool that provides B2B company profiles with data such as revenue, employee count, funding, and contact information to help sales teams find decision makers and build pipeline.

Terran OrbitalTerran Orbital manufactures small satellites and provides end-to-end satellite services including design, production, launch planning, mission operations, and in-orbit support. It serves military, civil, and commercial customers, primarily in the United States and allied aerospace and defense sectors.

StellantsystemsStellant Systems manufactures RF power amplification and spectrum products for space, defense, medical, scientific, and industrial applications serving both domestic and international markets.

Companies working in the same space as Exthymic.

Frequently asked questions

What does Exthymic do?: Exthymic is a company working on cell therapy manufacturing, aiming to make cancer cell therapies more accessible to patients who currently cannot obtain them. The founders describe backgrounds building manufacturing platforms and scaling production within the cell therapy industry.
Who are Exthymic's investors?: Exthymic's investors include KdT Ventures.
How much funding has Exthymic raised?: Exthymic has disclosed $10.2M raised across 1 round.
Where is Exthymic headquartered?: Exthymic is headquartered in San Diego, US.